Navigation Links
Spherix Announces Second Quarter 2010 Financial Results
Date:8/17/2010

BETHESDA, Md., Aug. 17 /PRNewswire-FirstCall/ -- Spherix Incorporated (Nasdaq: SPEX), an innovator in biotechnology for therapy in diabetes and the metabolic syndrome, and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today reported results for the three months ended June 30, 2010.

Recent and Upcoming Highlights

  • Pharmaceutical Development
  • Announced exploration of D-tagatose as a potential treatment for high triglycerides, a risk factor for atherosclerosis, myocardial infraction, and stroke
  • Acquired development and marketing rights for D-tagatose for triglycerides from the University of Kentucky Research Foundation
  • Goal of the triglycerides program is to develop a formulation, dose and dosing regimen appropriate for the lipid market segment
  • Anticipate a robust proof of concept in a Phase 2 clinical study and then seek a pharma partner for further development of the triglycerides drug product
  • Announce efficacy results of the Phase 3 trial for the treatment of Type 2 diabetes by mid-September 2010 and anticipated completion of the Phase 2 Dose Range trial by the end of 2010
  • Actively seeking a strategic relationship with a pharma company for the continued development of D-tagatose as a treatment for Type 2 diabetes
  • Conducted additional rounds of Medical Advisory Board meetings to provide clinical guidance for the development program for D-tagatose as a treatment for Type 2 diabetes and potential as a triglyceride therapy

  • Health Sciences Consulting
  • Recent and upcoming trade and professional shows:
  • 9th Vahouny Fiber Symposium, June 9, 2010, Bethesda, MD
  • ENDO Society Annual Meeting, June 19-22, San Diego, CA
  • American Diabetes Association Annual Meeting, June 2010, Orlando, FL

  • '/>"/>

  • SOURCE Spherix Incorporated
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related biology technology :

    1. Spherix Receives Nasdaq Letter Extending Minimum Bid Price Compliance Period
    2. Spherix Transfers Stock Listing to Nasdaq Capital Market
    3. Spherix Reports 3rd Quarter Earnings
    4. Spherix Announces 2008 Financial Results
    5. Spherix Recruiting New Independent Director to Regain NASDAQ Compliance
    6. Spherix Incorporated Announces the Death of A. Paul Cox, Jr., Chairman of the Board
    7. Spherix to Exhibit at the BIO 2009 International Convention
    8. Spherix Regains Full NASDAQ Compliance
    9. Spherix Announces Full-Scale Production of Pharmaceutical Tagatose
    10. Spherix Announces Termination of Arla License Agreement
    11. Spherix Reports Second Quarter 2009 Earnings
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/27/2015)... YORK , August 27, 2015 ... enhancing image processing functions in the human vision system, announced ... point guard Chris Paul to develop ... players who want to improve their real-life on-court performance. ... the court, whether it is shooting a ball or blocking ...
    (Date:8/27/2015)... ... August 27, 2015 , ... Proove Biosciences, ... data on the relationship of genetics and hypertension at the International Academy ... in Vancouver, British Columbia, Canada. The event, which boasts an extensive overview of ...
    (Date:8/26/2015)... ... August 26, 2015 , ... Lee Biosolutions, a ... development and manufacture of highly valued cardiac markers used in early detection of ... with protein chemistry has led to the development and commercialization of important cardiac ...
    (Date:8/26/2015)... and BEIJING , August 26, 2015 ... Impressive Acheivements  DiaCardio wins 1 st place  ... The competition, led in Israel by venture ... startups from countries including the US, China , ... Latin America .  Impressive achievement for ...
    Breaking Biology Technology:Eight-Time All-Star Chris Paul and GlassesOff Partner to Develop Innovative Mobile App Designed to Improve On-Court Performance 2Eight-Time All-Star Chris Paul and GlassesOff Partner to Develop Innovative Mobile App Designed to Improve On-Court Performance 3Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 2Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 3Lee Biosolutions Announces Increased Investment in the Development and Manufacturing of Biomarkers Used in Early Detection Of Heart Disease 2Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 2Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 3Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 4Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 5Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 6
    ... 4 Rochester Medical,Corporation (Nasdaq: ROCM ) today ... 2007., The Company reported sales of $8,223,000 for ... of last year. It also reported,net income of $272,000 ... income,of $31,467,000 or $2.59 per diluted share for the ...
    ... Baxter,s Cartago Plant First to be Awarded Shingo Prize Outside of North ... ... 4 Baxter International Inc.,s,(NYSE: BAX ) manufacturing facility in Cartago, ... The,facility -- the first to be awarded the Shingo Prize outside North ...
    ... MADISON, N.J., Feb. 4 Wyeth (NYSE: ... the Merrill Lynch 2008 Global,Pharmaceutical, Biotechnology and Medical ... a.m. Eastern Time. Presenting for Wyeth will be,Geno ... Wyeth,Pharmaceuticals., Wyeth,s presentation will be webcast live ...
    Cached Biology Technology:Rochester Medical Reports 31% Increase in Branded Sales Resulting in 9% Overall Sales Growth for the First Quarter 2Rochester Medical Reports 31% Increase in Branded Sales Resulting in 9% Overall Sales Growth for the First Quarter 3Rochester Medical Reports 31% Increase in Branded Sales Resulting in 9% Overall Sales Growth for the First Quarter 4Rochester Medical Reports 31% Increase in Branded Sales Resulting in 9% Overall Sales Growth for the First Quarter 5Rochester Medical Reports 31% Increase in Branded Sales Resulting in 9% Overall Sales Growth for the First Quarter 6Rochester Medical Reports 31% Increase in Branded Sales Resulting in 9% Overall Sales Growth for the First Quarter 7Baxter's Costa Rica Facility Recognized With Shingo Prize for Excellence in Manufacturing 2Wyeth to Present at the Merrill Lynch 2008 Global Pharmaceutical, Biotechnology and Medical Device Conference 2
    (Date:8/17/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... mobile commerce market and creator of the Wocket® smart ... The new marketing campaign is being spearheaded by an ... ( http://amplitudemarketing.com/ ) and TPMG ( http://tmpg.com/ ). ... driven marketing and brand awareness and has a client ...
    (Date:8/12/2015)... Aug. 12, 2015  New research unveiled at ... Android phones to steal users, fingerprints. Information released ... of fingerprint scanners on mobile devices, making the ... secure biometrics on mobile devices, HYPR Corp. recently ... convenient authentication systems with strong cryptographic security. More ...
    (Date:8/10/2015)... TELTOW, Germany , August 10, 2015 ... a world leader in Eye Tracking Technology for more ... OEM Eye Tracking Platform for integration into all consumer ... reference designs for seamless integration of eye tracking into ... HMDs and augmented reality smart glasses. Omnivision,s leading sensor ...
    Breaking Biology News(10 mins):NXT-ID, Inc. Launches Sales Campaign for Wocket Smart Wallet with Award Winning Marketing Team 2NXT-ID, Inc. Launches Sales Campaign for Wocket Smart Wallet with Award Winning Marketing Team 3HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 2HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 3SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3
    ... of mechanism causing cancer susceptibility, showing that tiny changes ... attract modifying "biochemical tags", effectively switching them off and ... The study and its findings are reported in ... The researchers, from the University of New South Wales ...
    ... environmental threats like bad weather, predators or oil spills, ... have analyzed blood samples to detect corticosterone levels in ... shown that corticosterone spikes can also be detected by ... the May 11 online edition of " Journal of ...
    ... of General Medical Sciences, part of the National Institutes ... Infectious Disease Agent Study for a research project at ... Stephen Eubank, professor. Infectious diseases pose one of ... Models of Infectious Disease Agent Study (MIDAS) is a ...
    Cached Biology News:'Methyl magnet' genes can cause family cancer risk 2A tool to measure stress hormone in birds -- feathers 2National Institutes of Health renews successful infectious disease research study 2National Institutes of Health renews successful infectious disease research study 3
    Topoisomerase I, isolated from wheat germ, is an enzyme capable of removing negative supercoils from covalently closed circular DNA (1)....
    Request Info...
    ... two highly efficient methods of identifying recombinant ... By using the large-scale screen method in ... is to transfer partial colonies of E. ... into the solutions provided by the kits ...
    The Proteome Profiler Human Phospho-MAPK Array Kit contains 4 membranes - each spotted in duplicate with 23 different MAPK antibodies....
    Biology Products: